Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Steiner, J. L. Articles by Griffith, E. E.E. Search for Related Content PubMed Citation Articles by Steiner, J. L. Articles by Griffith, E. E.E. Financing of Programs Other Ethics Issues

Best Practices: Developing Ethical Guidelines for Pharmaceutical Company Support in an Academic Mental Health Center

Introduction by the column editor: Interactions between the pharmaceutical industry and clinicians have important consequences for patient care. So a "best practices" look at this topic is welcomed. The authors of this month's column have initiated a quality-assurance process in their organization by developing ethical guidelines for such interactions. Guidelines are an early step toward the ultimate achievement of best practices. Over time, with monitoring of the impact of their guidelines on their institution, these authors will understand more about this vital theme. Attempts by other clinical organizations to develop guidelines will be needed to add to a generalized strategy for interactions between the pharmaceutical industry and the clinician.

This article has been cited by other articles:

				F. Y. Huang, D. S. Weiss, P. G. Fenimore, A. M. Fleming, E. Haller, J. E. Lichtmacher, and S. J. Eisendrath The Association of Pharmaceutical Company Promotional Spending With Resident Physician Prescribing Behavior Acad Psychiatry, December 1, 2005; 29(5): 500 - 501. [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2003 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us